ALI A CHAUDHRY

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease MARGATE, FL NPI 1295112191

General Payments — all program years on this page

$835.16

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 31
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $467.84 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $467.8420

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $179.817
2022 $141.382
2023 $46.132
2024 $467.8420

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103448344 ABBVIE INC. $32.85 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116233148 GlaxoSmithKline, LLC. $25.31 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116250954 GlaxoSmithKline, LLC. $19.95 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116541176 GlaxoSmithKline, LLC. $24.01 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116545224 GlaxoSmithKline, LLC. $22.63 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116658664 GlaxoSmithKline, LLC. $15.32 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117950804 Boehringer Ingelheim Pharmaceuticals, Inc. $25.55 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137508451 Takeda Pharmaceuticals U.S.A., Inc. $26.28 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137508455 Takeda Pharmaceuticals U.S.A., Inc. $19.94 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137508459 Takeda Pharmaceuticals U.S.A., Inc. $23.99 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140480062 Melinta Therapeutics, LLC $14.76 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140482966 Melinta Therapeutics, LLC $20.86 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140483160 Melinta Therapeutics, LLC $21.38 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140485807 Melinta Therapeutics, LLC $27.64 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141690144 Merck Sharp & Dohme LLC $21.88 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141864597 Merck Sharp & Dohme LLC $24.61 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141930637 Merck Sharp & Dohme LLC $25.85 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145056376 Mallinckrodt Hospital Products Inc. $16.10 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145056380 Mallinckrodt Hospital Products Inc. $21.68 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145056384 Mallinckrodt Hospital Products Inc. $37.25 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.